Final Glance: Biotechnology companies
News | 22 May 2012
NEW YORK ? Shares of some top biotechnology companies were mixed at the close of trading: Amgen Inc. fell $.41 or .6 percent, to $68.91. Biogen Idec rose $.07 or .1 percent, to $132.33. Celgene Corp. rose $.23 or .3 percent, to $69.65.
Click on the link to read the full article at CBS News
(This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
